Histopathology of calcineurin inhibitor-induced nephrotoxicity

Transplantation

Volumn 69, Issue 12 SUPPL., 2000, Pages

  Davies, David R ^a   Bittmann, Iris ^a   Pardo, Javier ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CYCLOSPORIN A;

CONFERENCE PAPER; GRAFT REJECTION; HISTOPATHOLOGY; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY TUBULE DISORDER; NEPHROTOXICITY; PRIORITY JOURNAL; VASCULAR DISEASE;

EID: 0343090809     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200006271-00003     Document Type: Conference Paper

References (21)

1. Mihatsch MJ, Ryffel B, Gudat F. The differential diagnosis between rejection and cyclosporine toxicity. Kidney Int 1995; 48: S63-S69.
2. Mihatsch MJ, Kyo M, Morozumi K, et al. The side-effects of cyclosporine-A and tacrolimus. Clin Nephrol 1998; 49: 356-363.
3. Myers BD, Sibley R, Newton L, et al. The long-term course of cyclosporine-associated chronic nephrotoxicity. Kidney Int 1988; 33: 590-600.
4. Andoh TF, Burdmann EA, Bennett WM. Nephrotoxicity of immunosuppressive drugs: experimental and clinical observations. Semin Nephrol 1997; 17: 34-45.
5. Dussol B, Reynaud-Gaubert M, Saingra Y, Daniel N, Berland Y. Acute tubular necrosis induced by a high level of cyclosporin A in a lung transplant. Transplantation; in press.
6. Shechter P. Acute tubular necrosis following high-dose cyclosporine A therapy. Eur J Clin Pharmacol 1996; 49: 521-523.
7. Mihatsch MJ, Thiel G, Ryffel B. Histopathology of cyclosporine nephrotoxicity. Transplant Proc 1988; 20(suppl 3): 759-771.
8. Griffiths MH, Crowe AV, Papadaki L, et al. Cyclosporin nephrotoxicity in heart and lung transplant recipients. QJM 1996; 89: 751-763.
9. Olyaei AJ, de Mattos AM, Bennett WM. Immunosuppressant-induced nephropathy: pathophysiology, incidence, and management. Drug Safety 1999; 21: 411-488.
10. Benigni A, Bruzzi I, Mister M, et al. Nature and mediators of mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year. Kidney Int 1999; 55: 674-685.
11. Ong ACM, Fine LG. Tubular-derived growth factors and cytokines in the pathogenesis of tubulointerstitial fibrosis: implications for human renal disease progression. Am J Kidney Dis 1994; 23: 205-209.
12. Suzuku T, Furusato M, Takasaki S, et al. Giant mitochondria in the epithelial cells of the proximal convoluted tubules of diseased human kidneys. Lab Invest 1975; 33: 578-590.
13. Kirwan PD. Giant mitochondria and multiple cilia in proximal convulted tubules of renal transplant patients receiving cyclosporine-A immunosuppression. Micron 1982; 13: 353-354.
14. Solez K, Racusen LC, Marcussen N, et al. Morphology of ischemic acute renal failure, normal function, and cyclosporine toxicity in cyclosporine-treated renal allograft recipients. Kidney Int 1993; 43: 1058-1067.
15. Bergstrand A, Bohman SO, Farnsworth A, et al. Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporine A: results of an international workshop. Clin Nephrol 1985; 24: 107-119.
16. Mihatsch MJ, Basler V, Curschellas E, et al. Giant mitochondria in "zero-hour" transplant biopsies. Ultrastruct Pathol 1992; 16: 277-282.
17. Antonovych TT, Sabnis SG, Austin HA, et al. Cyclosporine A-induced arteriolopathy. Transplant Proc 1988; 2(suppl 3): 951-958.
18. Moruzumi K, Gudat F, Thiel G, et al. Is cyclosporine associated glomerulopathy a new glomerular lesion in renal allografts using CSA? At: 14th International Congress of the Transplantation Society, August 6-21, 1992
19. Shulman H, Striker G, Deeg, HJ, et al. Nephrotoxicity of cyclosporine A after allogeneic marrow transplantation. N Engl J Med 1981; 305: 1392-1395.
20. Sibley RK, Rynasiewicz J, Ferguson RM, et al. Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone. Surgery 1983; 94: 225-234.
21. d'Ardenne AJ, Dunnill MS, Thomson JF, McWhinnie D, Wood RFM, Morris PJ. Cyclosporin and renal graft histology. J Clin Pathol 1986; 39: 145-151.